L. Bos (Amsterdam, Netherlands), J. Winck Fernandes Cruz (Vila Nova de Gaia, Portugal)
This session is built from abstracts published on the ERS Congress platform from 23 August, in an e-poster pdf format with a 3-minute audio narration. Participants and chairs of the session are invited to access all e-posters from 23 August to 4 September prior to the 1-hour live, online discussion scheduled from September 5-7. Please note that during live discussion there will be NO e-poster/abstract presentations, only discussion.
CPAP as a useful tool in COVID-19 related acute hypoxemic respiratory failure: Experience from 3 UKhospitals
Y. Ahmed (South end, United Kingdom), N. Ananda Setty (Basildon, United Kingdom), A. Roshdy (London, United Kingdom), D. Powrie (South end, United Kingdom), D. Amran (South end, United Kingdom), A. Elsheikh (South end, United Kingdom), S. Gokaraju (South end, United Kingdom), A. Tear (South end, United Kingdom), M. Noeman (london, United Kingdom), M. Darda (london, United Kingdom), I. El Sayed (alexandria, Egypt), V. Karunanithi (london, United Kingdom), A. Mahalingam (london, United Kingdom), M. Shafiq (london, United Kingdom), I. Abdulkhalik (london, United Kingdom), J. Samuel (london, United Kingdom)
|  |
Experience with high-flow nasal oxygen therapy in COVID-19 patients on a regular internal medicine ward
M. Hofer (Winterthur, Switzerland), M. Schmiedskamp (Winterthur, Switzerland), S. Rezek (Winterthur, Switzerland), N. Ott (Winterthur, Switzerland), I. Unger (Winterthur, Switzerland), G. Volk (Winterthur, Switzerland), J. Hetzel (Winterthur, Switzerland)
|  |
The use of pronation associated with non-invasive ventilator support in patients with severe SARS-CoV-2 pneumonia: preliminary data.
G. Garuti (Mirandola, Italy), E. Businarolo (Mirandola, Italy), R. Melara (Mirandola, Italy), L. Porrino (Mirandola, Italy), M. Simeone (Mirandola, Italy), V. Vezzani (Mirandola, Italy), C. Cilione (Mirandola, Italy), M. Moretti (Mirandola, Italy), A. Pignatti (Carpi, Italy), R. Murgia (Mirandola, Italy)
| |
Survival rates among COVID-19 patients treated with high flow nasal oxygen therapy with a do-not-intubate-order: an observational study
I. Smesseim (Amsterdam, Netherlands), B. Atasever (Haarlem, Netherlands), L. Hessels (Alkmaar, Netherlands), D. Korevaar (Amsterdam, Netherlands), L. Bos (Amsterdam, Netherlands), B. Goorhuis (Amsterdam, Netherlands), E. Nossent (Amsterdam, Netherlands), K. Mooij-Kalverda (Amsterdam, Netherlands), P. Bonta (Amsterdam, Netherlands)
| |
The impact of embedding trial recruitment into a clinical care pathway
K. Yip (Birmingham, United Kingdom), S. Gompertz (Birmingham, United Kingdom), C. Snelson (Birmingham, United Kingdom), J. Willson (Birmingham, United Kingdom), S. Madathil (Birmingham, United Kingdom), S. Huq (Birmingham, United Kingdom), F. Rauf (Birmingham, United Kingdom), N. Salmon (Birmingham, United Kingdom), J. Tracey (Birmingham, United Kingdom), B. Cooper (Birmingham, United Kingdom), K. Filby (Birmingham, United Kingdom), D. Parekh (Birmingham, United Kingdom), D. Dosanjh (Birmingham, United Kingdom)
| |
Non-Invasive Respiratory Support outcomes in patients with SARS-Cov-2 and Respiratory Failure managed in an Acute Respiratory Care Unit (ARCU)
M. Barik (Wakefield, United Kingdom), S. Boot (Wakefield, United Kingdom), A. Gondker (Wakefield, United Kingdom), J. Hogg (Wakefield, United Kingdom), A. Johnson (Wakefield, United Kingdom), M. Thirumaran (Wakefield, United Kingdom), H. Elfaki (Wakefield, United Kingdom), A. Dwarakanath (Wakefield, United Kingdom)
| |
First and second waves results of COVID-19 patients treated with non-invasive respiratory therapies outside the ICU: unicentric, observational study
V. Parra León (Madrid, Spain), D. López-Padilla (Madrid, Spain), J. Terán Tinedo (Madrid, Spain), S. Suárez Escudero (Madrid, Spain), S. López Martín (Madrid, Spain), E. Ojeda Castillejo (Madrid, Spain), F. Caballero Segura (Madrid, Spain), B. Recio Moreno (Madrid, Spain), C. Castro Riera (Madrid, Spain), L. Puente Maestú (Madrid, Spain)
| |
A retrospective study of the use of ROX index to predict failure in patients receiving CPAP for COVID-19
A. Yousuf (Watford, United Kingdom), D. Gottlieb (Watford, United Kingdom), A. Aggarwal (Watford, United Kingdom), B. Peacock (Watford, United Kingdom), S. Konda (Watford, United Kingdom)
| |
Risk factors for noninvasive ventilatory support failure in patients with COVID-19 pneumonia
I. Farinha (Coimbra, Portugal), A. Tenda Cunha (Coimbra, Portugal), L. Gomes (Coimbra, Portugal), S. Pereira (Coimbra, Portugal), M. Matias (Coimbra, Portugal), J. Pina Cabral (Coimbra, Portugal), C. Canizes (Coimbra, Portugal), F. Costa (Coimbra, Portugal)
| |
Predictors of weaning from helmet CPAP in COVID-19: preliminary results from a retrospective observational study
D. Radovanovic (Milano (MI), Italy), S. Pini (Milano (MI), Italy), M. Saad (Milano (MI), Italy), L. Perotto (Milano (MI), Italy), M. Rizzi (Milano (MI), Italy), P. Santus (Milano (MI), Italy)
| |
Early use of Helmet CPAP reduces mortality rate in patients with COVID-19
F. Andrani (Piacenza, Italy), A. Mangia (Piacenza, Italy), E. Bucchioni (Piacenza, Italy), S. Chiesa (Piacenza, Italy), P. Magri (Piacenza, Italy), A. Ielpo (Piacenza, Italy), S. Di Stasi (Piacenza, Italy), C. Cagnoni (Piacenza, Italy), D. Aschieri (Piacenza, Italy), M. Stabile (Piacenza, Italy), C. Maestri (Piacenza, Italy), C. Franco (Piacenza, Italy)
| |
CPAP improves oxygen saturation and breathing rate in COVID-19 patients
M. Schmiedeskamp (Winterthur, Switzerland), M. Hofer (Winterthur, Switzerland), S. Rezek (Winterthur, Switzerland), I. Unger (Winterthur, Switzerland), N. Ott (Winterthur, Switzerland), G. Volk (Winterthur, Switzerland), J. Hetzel (Winterthur, Switzerland)
| |
Monitoring lung mechanics by oscillometry in COVID 19 ARDS receiving non-invasive ventilation: a pilot study
C. Torregiani (Trieste, Italy), C. Veneroni (Milano, Italy), P. Confalonieri (Trieste, Italy), G. Citton (Trieste, Italy), F. Salton (Trieste, Italy), M. Jaber (Trieste, Italy), M. Confalonieri (Trieste, Italy), R. Dellaca' (Milano, Italy)
| |
The impact of the COVID-19 pandemic on a domiciliary non-invasive ventilation (D-NIV) service referral
S. Mansell (London, United Kingdom), S. Mandal (London, United Kingdom)
| |
The effect of the COVID-19 pandemic on response times for acute non-invasive ventilation (NIV) set-ups
D. Inglis (Birmingham (West Midlands), United Kingdom), P. Antoine-Pitterson (Birmingham (West Midlands), United Kingdom), E. Gallagher (Birmingham (West Midlands), United Kingdom), B. Jones (Birmingham (West Midlands), United Kingdom), R. Mukherjee (Birmingham (West Midlands), United Kingdom), R. Mukherjee (Birmingham (West Midlands), United Kingdom)
| |
Validity of APACHE II and SOFA score in Predicting Prognosis in Mechanically Ventilated Patients in Respiratory ICU
N. Choudhry (Bareilly, India), L. Singh (Bareilly, India), R. Tandon (Bareilly, India), U. Khattri (Bareilly, India)
| |
Impact on outcome of non invasive ventilation after extubation
L. Debbiche (Ariana, Tunisia), S. Ayed (Ariana, Tunisia), S. Sellaouti (Ariana, Tunisia), F. Daoud (Ariana, Tunisia), A. Jamoussi (Ariana, Tunisia), E. Rachdi (Ariana, Tunisia), F. Jarraya (Ariana, Tunisia), J. Ben Khelil (Ariana, Tunisia), M. Besbes (Ariana, Tunisia)
| |
Experimental use of CPAP device for emergency high-flow nasal oxygen therapy
P. Pobeha (Košice, Slovakia), J. Hack (Košice, Slovakia), P. Joppa (Košice, Slovakia)
| |
Predictors of persistent hypercapnia after an hypercapnic AECOPD
J. Bräunlich (Leipzig, Germany), K. Turba (Leipzig, Germany), H. Wirtz (Leipzig, Germany)
| |
Characteristics of obese patients admitted in a department of pneumology with acute hypercapnic respiratory failure (AHRF): an observational study in a north African population
B. Moustapha (Sfax, Tunisia), G. Rahma (Sfax, Tunisia), K. Amina (Sfax, Tunisia), J. Jihen (Sfax, Tunisia), M. Nedia (Sfax, Tunisia), J. Yassin (Sfax, Tunisia), K. Wajdi (Sfax, Tunisia), K. Samy (Sfax, Tunisia), A. EL-EUCH (Sfax, Tunisia)
| |